• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过振动网式雾化器和喷射雾化器进行GG的呼吸道给药。

Respiratory Delivery of GG by Vibrating-Mesh and Jet Nebulisation.

作者信息

Byun Alex Seungyeon, Vitetta Luis, Chan Hak-Kim, Kwok Philip Chi Lip

机构信息

Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, NSW 2006, Australia.

出版信息

Pharmaceutics. 2024 Oct 14;16(10):1326. doi: 10.3390/pharmaceutics16101326.

DOI:10.3390/pharmaceutics16101326
PMID:39458655
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11510752/
Abstract

BACKGROUND

The use of probiotic bacteria to improve lung health has been gaining interest. Although the oral delivery of probiotics and their effects are well documented, there is currently limited knowledge on the respiratory delivery of probiotics.

OBJECTIVES

This study aimed to investigate whether nebulisation is suitable for delivering GG (LGG) into the lungs for the potential treatment of bacterial pulmonary infections.

METHODS

It compared the dose output and aerosol performance of a vibrating-mesh nebuliser (VMN) and a jet nebuliser (JN) in nebulising LGG suspended in de Man Rogosa Sharpe (MRS) broth, phosphate-buffered saline (PBS), or normal saline (0.9% / sodium chloride in water).

RESULTS

The VMN consistently produced a higher output than the JN for all liquid media, indicating that VMN was more efficient. The fine-particle fractions of both nebulisers were comparable for a given medium. The highest fine-particle fraction was achieved with LGG suspended in MRS broth for both nebulisers (20.5 ± 2.8% for VMN; 18.7 ± 3.4% for JN). This suggests that the aerosol performance of nebulised probiotics may depend on the medium in which the probiotic bacteria were suspended.

CONCLUSIONS

Therefore, this study demonstrated that the nebulisation efficiency of LGG depended on the nebuliser type and liquid medium of the probiotic suspension.

摘要

背景

使用益生菌改善肺部健康已引起关注。尽管益生菌的口服给药及其效果已有充分记录,但目前关于益生菌经呼吸道给药的知识有限。

目的

本研究旨在调查雾化是否适合将鼠李糖乳杆菌(LGG)输送至肺部以潜在治疗细菌性肺部感染。

方法

比较了振动网孔雾化器(VMN)和喷射雾化器(JN)在雾化悬浮于德氏改良罗氏培养基(MRS肉汤)、磷酸盐缓冲盐水(PBS)或生理盐水(0.9%/水中氯化钠)中的LGG时的剂量输出和气溶胶性能。

结果

对于所有液体介质,VMN始终比JN产生更高的输出,表明VMN效率更高。对于给定介质,两种雾化器的细颗粒部分相当。两种雾化器在MRS肉汤中悬浮的LGG时均达到最高细颗粒部分(VMN为20.5±2.8%;JN为18.7±3.4%)。这表明雾化益生菌的气溶胶性能可能取决于益生菌悬浮的介质。

结论

因此,本研究表明LGG的雾化效率取决于雾化器类型和益生菌悬浮液的液体介质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/79cd44aeb7ef/pharmaceutics-16-01326-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/ffe1af1a9373/pharmaceutics-16-01326-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/714ff7d44184/pharmaceutics-16-01326-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/cdc14040376e/pharmaceutics-16-01326-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/d82438cdf253/pharmaceutics-16-01326-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/a66d984dbf3f/pharmaceutics-16-01326-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/1c35b7f16ca8/pharmaceutics-16-01326-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/cbe862c59ddd/pharmaceutics-16-01326-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/98cb15b6f092/pharmaceutics-16-01326-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/2f0024079081/pharmaceutics-16-01326-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/4aa79f7d483a/pharmaceutics-16-01326-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/79cd44aeb7ef/pharmaceutics-16-01326-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/ffe1af1a9373/pharmaceutics-16-01326-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/714ff7d44184/pharmaceutics-16-01326-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/cdc14040376e/pharmaceutics-16-01326-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/d82438cdf253/pharmaceutics-16-01326-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/a66d984dbf3f/pharmaceutics-16-01326-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/1c35b7f16ca8/pharmaceutics-16-01326-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/cbe862c59ddd/pharmaceutics-16-01326-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/98cb15b6f092/pharmaceutics-16-01326-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/2f0024079081/pharmaceutics-16-01326-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/4aa79f7d483a/pharmaceutics-16-01326-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a186/11510752/79cd44aeb7ef/pharmaceutics-16-01326-g011.jpg

相似文献

1
Respiratory Delivery of GG by Vibrating-Mesh and Jet Nebulisation.通过振动网式雾化器和喷射雾化器进行GG的呼吸道给药。
Pharmaceutics. 2024 Oct 14;16(10):1326. doi: 10.3390/pharmaceutics16101326.
2
Nebuliser therapy in critical care: The past, present and future.重症监护中的雾化治疗:过去、现在与未来。
J Intensive Care Soc. 2024 Feb;25(1):78-88. doi: 10.1177/17511437231199899. Epub 2023 Sep 20.
3
The effects of suspension particle size on the performance of air-jet, ultrasonic and vibrating-mesh nebulisers.悬浮颗粒大小对空气喷射式、超声式和振动筛网式雾化器性能的影响。
Int J Pharm. 2014 Jan 30;461(1-2):234-41. doi: 10.1016/j.ijpharm.2013.11.022. Epub 2013 Nov 22.
4
Prospective randomised unblinded comparison of sputum viscosity for three methods of saline nebulisation in mechanically ventilated patients: A pilot study protocol.前瞻性随机非盲比较三种机械通气患者生理盐水雾化方法的痰液黏度:一项初步研究方案。
PLoS One. 2023 Aug 17;18(8):e0290033. doi: 10.1371/journal.pone.0290033. eCollection 2023.
5
In vitro evaluation of disposable transport ventilators with combination aerosol therapy.一次性运送呼吸机联合雾化治疗的体外评估。
BMJ Open Respir Res. 2021 Mar;8(1). doi: 10.1136/bmjresp-2020-000739.
6
Vibrating Mesh Nebulisation of Pro-Antimicrobial Peptides for Use in Cystic Fibrosis.用于囊性纤维化的抗菌肽的振动网雾化
Pharmaceutics. 2019 May 17;11(5):239. doi: 10.3390/pharmaceutics11050239.
7
Mannitol delivery by vibrating mesh nebulisation for enhancing mucociliary clearance.振动网孔雾化给予甘露醇以增强黏液纤毛清除功能。
J Pharm Sci. 2011 Jul;100(7):2693-702. doi: 10.1002/jps.22494. Epub 2011 Jan 31.
8
Nebuliser systems for drug delivery in cystic fibrosis.用于囊性纤维化药物递送的雾化器系统。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD007639. doi: 10.1002/14651858.CD007639.pub2.
9
Surfactant nebulisation: safety, efficiency and influence on surface lowering properties and biochemical composition.表面活性剂雾化:安全性、有效性及其对表面降低特性和生化组成的影响。
Intensive Care Med. 1997 Apr;23(4):456-62. doi: 10.1007/s001340050358.
10
Effect of nebuliser and patient interface type on fugitive medical aerosol emissions in adult and paediatric patients.雾化器和患者接口类型对成人和儿科患者逃逸性医用气溶胶排放的影响。
Eur J Pharm Sci. 2023 Aug 1;187:106474. doi: 10.1016/j.ejps.2023.106474. Epub 2023 May 22.

本文引用的文献

1
Dry Powder Inhaler Formulation of Targeting Infection in Bronchiectasis Maintenance Therapy.用于支气管扩张症维持治疗中靶向感染的干粉吸入剂配方
Pharmaceutics. 2024 Jul 25;16(8):980. doi: 10.3390/pharmaceutics16080980.
2
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa.含具有抗铜绿假单胞菌活性的乳酸菌的吸入性粉末的研制。
Int J Antimicrob Agents. 2024 Jan;63(1):107001. doi: 10.1016/j.ijantimicag.2023.107001. Epub 2023 Oct 13.
3
Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy.
用于预防和治疗呼吸道合胞病毒、严重急性呼吸综合征冠状病毒 2 型、人类免疫缺陷病毒、狂犬病和细菌感染的单克隆抗体:来自世界传染病和免疫疾病协会以及意大利抗感染治疗学会的最新更新。
Front Immunol. 2023 May 15;14:1162342. doi: 10.3389/fimmu.2023.1162342. eCollection 2023.
4
Therapeutics for COVID-19.治疗 COVID-19 的方法。
Nat Microbiol. 2023 May;8(5):771-786. doi: 10.1038/s41564-023-01356-4. Epub 2023 May 4.
5
Probiotics for preventing acute upper respiratory tract infections.益生菌预防急性上呼吸道感染。
Cochrane Database Syst Rev. 2022 Aug 24;8(8):CD006895. doi: 10.1002/14651858.CD006895.pub4.
6
Trends in the global burden of lower respiratory infections: the knowns and the unknowns.全球下呼吸道感染负担的趋势:已知与未知
Lancet Infect Dis. 2022 Nov;22(11):1523-1525. doi: 10.1016/S1473-3099(22)00445-5. Epub 2022 Aug 11.
7
Nasal-spraying Bacillus spores as an effective symptomatic treatment for children with acute respiratory syncytial virus infection.鼻腔喷雾接种芽孢杆菌作为急性呼吸道合胞病毒感染患儿的有效对症治疗方法。
Sci Rep. 2022 Jul 20;12(1):12402. doi: 10.1038/s41598-022-16136-z.
8
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
9
Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19.雾化吸入等渗羟氯喹气雾剂用于COVID-19的潜在治疗
Pharmaceutics. 2021 Aug 14;13(8):1260. doi: 10.3390/pharmaceutics13081260.
10
Towards the sustainable discovery and development of new antibiotics.迈向新型抗生素的可持续发现与开发。
Nat Rev Chem. 2021;5(10):726-749. doi: 10.1038/s41570-021-00313-1. Epub 2021 Aug 19.